-
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Average Rating of "Buy" from Brokerages
Source: Buzz FX / 09 Oct 2024 02:01:11 America/Chicago
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Average Rating of "Buy" from Brokerages Written by MarketBeat October 9, 2024 Share Link copied to clipboard. ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Get Free Report ) has been assigned an
Read more...